CP-547632, a new oral VEGFR-2 tyrosine kinase inhibitor, advances to studies in humans April 11, 2002
New antimitotic indole-oxazoline derivative exhibits antivascular and proapoptotic effects April 11, 2002
Proof of principle demonstrated for Corixa's duocarmycin/tumor-activated prodrug approach April 11, 2002
NVP-LAF-389 induces amino-terminus changes in cytosolic protein indicative of enzyme inhibition April 11, 2002
Inhibitors of VEGF useful for cancer and rheumatoid arthritis described in AstraZeneca patents April 10, 2002
Cdc25 inhibitor described at AACR meeting as warranting further evaluation as an anticancer agent April 10, 2002
RSS